Alzamend Neuro, Inc.
NASDAQ:ALZN
1.64 (USD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||
Current Assets: | |||||||||
Cash & Cash Equivalents
| 0.376 | 5.141 | 14.064 | 1.929 | 0.09 | 0.043 | 0.545 | 0.005 | 0.001 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 0.376 | 5.141 | 14.064 | 1.929 | 0.09 | 0.043 | 0.545 | 0.005 | 0.001 |
Net Receivables
| 0 | 0 | 0 | 0.016 | 0.194 | 0.285 | 0.424 | 0 | 0 |
Inventory
| 0 | 0 | 0 | -0.016 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 0.079 | 0.695 | 0.35 | 0.983 | 1.529 | 1.173 | 1.447 | 0.052 | 0.004 |
Total Current Assets
| 0.455 | 5.836 | 14.414 | 2.913 | 1.814 | 1.501 | 2.416 | 0.057 | 0.006 |
Non-Current Assets: | |||||||||
Property, Plant & Equipment, Net
| 0.176 | 0.08 | 0.103 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0 | -0 | 0 | 0.353 | 0 | 0 | 0 | 0.075 | 0.025 |
Total Non-Current Assets
| 0.176 | 0.08 | 0.103 | 0.353 | 0 | 0 | 0 | 0.075 | 0.025 |
Total Assets
| 0.632 | 5.916 | 14.516 | 2.913 | 1.814 | 1.501 | 2.416 | 0.132 | 0.031 |
Liabilities & Equity: | |||||||||
Current Liabilities: | |||||||||
Account Payables
| 2.925 | 2.87 | 1.163 | 0.504 | 0.93 | 1.105 | 0.09 | 0.126 | 0.003 |
Short Term Debt
| 0.301 | 0 | 0 | 0.335 | 0 | 0 | 0 | 0.591 | 0.003 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| -3.226 | 0 | 0 | 0 | -0 | -0 | 0 | -0 | 0 |
Other Current Liabilities
| 3.226 | 0 | 0.002 | 0.061 | 0.063 | 0.079 | 0.007 | 0 | 0.025 |
Total Current Liabilities
| 3.226 | 2.87 | 1.165 | 0.9 | 0.992 | 1.184 | 0.097 | 0.717 | 0.031 |
Non-Current Liabilities: | |||||||||
Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0 | 1.163 | 0 | 0 | 1.105 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 0 | 0 | 1.163 | 0 | 0 | 1.105 | 0 | 0 | 0 |
Total Liabilities
| 3.226 | 2.87 | 1.165 | 0.9 | 0.992 | 1.184 | 0.097 | 0.717 | 0.031 |
Equity: | |||||||||
Preferred Stock
| 0 | 14.883 | 14.883 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 0 | 0.01 | 0.01 | 0.007 | 0.006 | 0.006 | 0.005 | 0.003 | 0.005 |
Retained Earnings
| -54.02 | -44.073 | -29.194 | -16.832 | -11.786 | -7.376 | -2.513 | -1.581 | -0.012 |
Accumulated Other Comprehensive Income/Loss
| 0 | -14.883 | -14.883 | -14.883 | -14.983 | -15 | -0.005 | 0 | -0.003 |
Other Total Stockholders Equity
| 51.426 | 47.108 | 42.536 | 33.722 | 27.584 | 22.686 | 4.832 | 0.993 | 0.01 |
Total Shareholders Equity
| -2.594 | 3.046 | 13.352 | 2.013 | 0.822 | 0.317 | 2.319 | -0.585 | -0 |
Total Equity
| -2.594 | 3.046 | 13.352 | 2.013 | 0.822 | 0.317 | 2.319 | -0.585 | -0 |
Total Liabilities & Shareholders Equity
| 0.632 | 5.916 | 14.516 | 2.913 | 1.814 | 1.501 | 2.416 | 0.132 | 0.031 |